The collapse of the Soviet Union in 1991 led to the formation of independent republics, each of which sets its own unique path for further development. In this regard, each pharmaceutical market of the post-Soviet countries also has its own features. For many international companies, these markets still remain to be uncharted territory.
Nevertheless, the markets of the CIS countries are promising and have a great potential for growth. According to IQVIA experts, the pharmaceutical markets of the CIS countries in the coming years will grow by an average of 7.6%, which is about 1.5 times faster than the pharmaceutical markets of the developed countries.
We selected 7 ex-Soviet countries in order to give a general view of them, by comparing the main indicators and describing the main pharmaceutical distributors. This publication will help you, having tested the main landscape, to get an idea of the surveyed markets, and maybe to determine a general plan for further access to them.
|Description of the largest pharmaceutical distributors in each market||Number of pharmacies in each country|
|Pharma consumption per capita||The ratio of market shares of local and foreign companies, as well as Rx/OTC sales ratio|
|Number of hospitals in each country||Number of doctors in each country|
|Series:||Pharmaceutical country report|
|List of countries reviewed:||
|Number of pages:||12|
|Get the report:||Download|